• Compensation up to $1450 for travel
  • No-cost study medication
  • No-cost study-related care from local doctors and specialists with no waiting lists

There is no obligation to enquire and referrals are not needed.

Ready to get started? Click Here.

You may qualify for local research studies

Rheumatoid Arthritis is an uncommon form of arthritis. Rheumatoid Arthritis is an autoimmune disease that occurs when your immune system attacks the lining of your joints. This causes joint pain, stiffness, swelling, and redness that can move to any joint, at any time. You may also have other symptoms like feeling tired or having a fever.

Better treatment options are needed for people who suffer with Rheumatoid Arthritis. Right now, local doctors are looking for people who have Rheumatoid Arthritis to participate in local research studies.

You may qualify for local research studies. But don’t delay — space is limited!

Not sure if you have Rheumatoid Arthritis? Check out this chart to figure out what type of arthritis you may have.

Osteoarthritis Rheumatoid Arthritis
Age symptoms start Later in life Usually before the age of 50
How symptoms start Slowly over many years Suddenly, over weeks or months
Joint pain Same joints effected all the time Pain comes and goes, and can affect multiple joints at any time
Other symptoms None. Symptoms are limited to joint pain. Fatigue and general feeling of illness
*In a clinical research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. Reasonable payments may be made for participation and the length of the study may vary.

Ready to get started?

Click here.

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes


AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.